News Conference News ACC 2018 Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint Caitlin E. Cox March 19, 2018
News Conference News ACC 2018 NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients Shelley Wood March 10, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2018 Shelley Wood March 01, 2018
News Daily News Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients L.A. McKeown February 07, 2018
News Daily News Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition Michael O'Riordan January 26, 2018
News Daily News One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk L.A. McKeown January 18, 2018
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Daily News Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria Caitlin E. Cox October 18, 2017
News Daily News Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR Shelley Wood October 10, 2017
News Daily News Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis Caitlin E. Cox September 29, 2017
News Conference News PCR London Valves 2017 Valve Deterioration and Durability Definitions Now Standardized in New Guide Shelley Wood September 25, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Daily News Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR Leah Lawrence August 10, 2017
News Conference News EuroPCR 2017 More Early Stroke With SAVR Than TAVR in SURTAVI Shelley Wood May 18, 2017
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017